Jim Cramer reminds investors that market pain is needed to prevent endless price hikes

Jim Cramer reminds investors that market pain is needed to prevent endless price hikes


CNBC’s Jim Cramer on Thursday reminded investors that pain in the stock market is unfortunately necessary for the Federal Reserve to win against inflation.

“Nobody wants to root for layoffs or lower stock prices. But the alternative is persistently high inflation — endless price increases for everything — and nobody wants that either,” he said.

Stocks fell on Thursday after fresh data indicated that the labor market remains strong, despite the Fed’s aggressive interest rate hikes to tamp down rising prices. 

Cramer explained that while the Fed needs to make it so that companies can no longer raise prices for goods and services, it’s inevitable that such an outcome will hurt portfolios.

“Lower home prices – it’s good if you’re looking for a house, but it’s awful if you own shares in homebuilder Lennar,” he said as an example. “In other words, there’s no free lunch for you, the investor.”

And while it’s unclear when the central bank will be able to roll back its interest rate increases and stop hurting the market, he said that the release of the nonfarm payrolls report on Friday will shed more light on the state of inflation.

“If it doesn’t show higher unemployment with no wage growth, the Fed will need to keep aggressively raising interest rates,” Cramer said.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
Business

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy

Rear Admiral Erica G. Schwartz. U.S. Department of Health and Human Services President Donald Trump on Thursday nominated Erica Schwartz to serve as director of the Centers for Disease Control and Prevention, concluding a monthslong effort to choose a permanent leader of the embattled health agency.  Schwartz will have to be confirmed by the Senate, […]

Read More
RFK Jr.’s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Business

RFK Jr.’s peptide policy could boost Hims & Hers as its GLP-1 business evolves

Piotr Swat | Lightrocket | Getty Images As its high-margin compounded GLP-1 business evolves, Hims & Hers Health may be finding a new opportunity in peptides. Shares of the telehealth company jumped Thursday after HHS Secretary Robert F. Kennedy Jr. announced Wednesday that the FDA plans to convene a Pharmacy Compounding Advisory Committee meeting to […]

Read More
Netflix reports earnings after the bell. Here’s what to expect
Business

Netflix reports earnings after the bell. Here’s what to expect

The Netflix logo is seen on an office building in Los Angeles, California, on Feb. 5, 2026. Michael Yanow | Nurphoto | Getty Images Netflix kicks off earnings season for media companies on Thursday with a quarterly report that Wall Street hopes will give more updates on the company’s path forward after walking away from […]

Read More